a public good project by the
Synthesis
Company
of California

© 2026

Raymond S Hurst | doi.page

0 works0 citations0 h-index

Raymond S Hurst

Pfizer (United States)(US)Ark Therapeutic (United States)(US)C4 Therapeutics (United States)(US)

Publications by Year

Research Areas

Pharmacological Effects and Toxicity Studies, Electroconvulsive Therapy Studies, Nicotinic Acetylcholine Receptors Study, Neuroscience and Neuropharmacology Research, Epilepsy research and treatment

Most-Cited Works

→ trp, a Novel Mammalian Gene Family Essential for Agonist-Activated Capacitative Ca2+ Entry(1996)687 cited
→ Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid(2006)533 cited
→ Nicotinic acetylcholine receptors: From basic science to therapeutics(2012)522 cited
→ A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:In VitroandIn VivoCharacterization(2005)442 cited
→ Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation(2007)399 cited
→ Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease(2003)

353 cited

→ Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease(1999)350 cited

→ Cloning and Expression of a Novel Mammalian Homolog ofDrosophila Transient Receptor Potential (Trp) Involved in Calcium Entry Secondary to Activation of Receptors Coupled by the Gq Class of G Protein(1997)331 cited

→ Neuropsychopharmacology(2010)323 cited

→ The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats(2005)223 cited